Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same author

Proton FLASH preserves neurocognition across delivery techniques: implications for clinical translation in pediatric brain tumors.

bioRxiv : the preprint server for biology·2026
Same author

Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer.

International journal of particle therapy·2026
Same author

A Hybrid Model for Copper Futures Price Forecasting Utilizing Complexity-Aware Variational Mode Decomposition and Reconstruction and Multi-Behavior-Triggered Interaction Modeling.

Entropy (Basel, Switzerland)·2026
Same author

The Joint Effect of Stress Hyperglycemia Ratio and Inflammatory Burden Exacerbates Mortality Risk and Prolongs ICU Stay in Sepsis: A Combined Analysis.

Infection and drug resistance·2026
Same author

Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Sep 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Evaluating Proton Dose and Associated Range Uncertainty Using Daily Cone-Beam CT.

Heng Li1, William T Hrinivich1, Hao Chen1

  • 1Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Frontiers in Oncology
|April 22, 2022
PubMed
Summary

Daily cone-beam CT (CBCT) shows higher range uncertainties in proton therapy dose calculations than CT scans. However, CBCT-based dose calculations are suitable for daily validation in select proton therapy patients.

Keywords:
CBCTdose calculationproton radiation therapy (PBT)radiation measurementradiation therapy

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

Related Experiment Videos

Last Updated: Sep 26, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Imaging Science

Background:

  • Proton therapy offers precise dose delivery, but accurate range determination is crucial.
  • Cone-beam CT (CBCT) is increasingly used for image guidance in proton therapy.
  • Evaluating range uncertainties from CBCT is essential for ensuring treatment accuracy.

Purpose of the Study:

  • To quantitatively assess range uncertainties in proton dose calculations using daily CBCT images compared to conventional CT.
  • To validate the accuracy of CBCT-based range and dose calculations using a measurement-based technique.
  • To determine the suitability of CBCT for daily dose validation in proton therapy.

Main Methods:

  • Developed a measurement-based technique to evaluate range uncertainties.
  • Created intensity-modulated proton therapy (IMPT) plans for head and thorax phantoms.
  • Measured dose distributions using a 2D ion chamber array and compared them with CT and CBCT calculations.
  • Recalculated IMPT plans for a thymoma patient on multiple CBCT and CT datasets.

Main Results:

  • Head phantom: CBCT range uncertainty was 1.2% vs. 0.5% for CT.
  • Thorax phantom: CBCT range uncertainty was 2.1% vs. 0.8% for CT.
  • Thymoma patient: Breath-hold uncertainty caused up to 8 mm anatomy change, impacting dose calculation.

Conclusions:

  • The developed measurement-based method is sensitive for evaluating range uncertainties.
  • CBCT-based dose calculations show acceptable accuracy for daily validation in specific proton therapy cases.
  • CBCT can be a valuable tool for adaptive proton therapy planning and quality assurance.